Package 45802-066-01

Brand: azelastine hydrochloride and fluticasone propionate

Generic: azelastine hydrochloride, fluticasone propionate
NDC Package

Package Facts

Identity

Package NDC 45802-066-01
Digits Only 4580206601
Product NDC 45802-066
Description

1 BOTTLE in 1 CARTON (45802-066-01) / 120 SPRAY, METERED in 1 BOTTLE

Marketing

Marketing Status
Marketed Since 2021-03-01
Brand azelastine hydrochloride and fluticasone propionate
Generic azelastine hydrochloride, fluticasone propionate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["NASAL"], "spl_id": "26745ea7-7084-4000-9571-5795c176cc6f", "openfda": {"unii": ["0L591QR10I", "O2GMZ0LF5W"], "rxcui": ["1797847"], "spl_set_id": ["625ffdd0-8486-49af-8e77-6aa663be5ac7"], "manufacturer_name": ["Padagis Israel Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (45802-066-01)  / 120 SPRAY, METERED in 1 BOTTLE", "package_ndc": "45802-066-01", "marketing_start_date": "20210301"}], "brand_name": "AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE", "product_id": "45802-066_26745ea7-7084-4000-9571-5795c176cc6f", "dosage_form": "SPRAY, METERED", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]"], "product_ndc": "45802-066", "generic_name": "azelastine hydrochloride, fluticasone propionate", "labeler_name": "Padagis Israel Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "AZELASTINE HYDROCHLORIDE AND FLUTICASONE PROPIONATE", "active_ingredients": [{"name": "AZELASTINE HYDROCHLORIDE", "strength": "137 ug/1"}, {"name": "FLUTICASONE PROPIONATE", "strength": "50 ug/1"}], "application_number": "ANDA208111", "marketing_category": "ANDA", "marketing_start_date": "20210301", "listing_expiration_date": "20261231"}